NOVOPROTEIN Trademark

Trademark Overview


On Saturday, September 3, 2011, a trademark application was filed for NOVOPROTEIN with the United States Patent and Trademark Office. The USPTO has given the NOVOPROTEIN trademark a serial number of 85414847. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 7, 2019. This trademark is owned by Novoprotein Scientific Inc.. The NOVOPROTEIN trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Protein and biochemical compounds in the nature of peptides for industrial, laboratory and research use; chemical analysis kits containing protein and peptides for industrial, laboratory, and research use; protein and biochemical compounds in the nature of peptides in raw material form for scientific research; cytokines and recombinant proteins for laboratory and research use; bio-chemicals, namely, antibodies for laboratory and research use; enzymes for laboratory and research use; enzymes derived from biotechnological processes for use in industry; enzymes for scientific and research purposes; biochemical reagents used for non-medical purposes; molecular biology reagents for laboratory or research use; protein detection and analysis reagents for laboratory or research use; diagnostic enzymes and reagents for laboratory or research use; and enzyme substrates for laboratory or research use

Research and development in the biotechnology fields, namely, conducting protein expression and purification, using mammalian, Baculovirus insect cell, E. coli, and yeast cell expression systems for protein expression and purification, large scale protein production in a gram scale, antibody production, custom rabbit polyclonal antibody production, hybridoma and in vitro monoclonal antibody production, antibody fragmentation, antibody labeling, protein modification, PEGylation, metabolic labeling with stable isotopes, protein crystallization, crystal screen and optimization, co-crystallization with compounds or ligands, molecular cloning, gene synthesis, site-directed mutagenesis, subcloning, and large scale plasmid production
novoprotein

General Information


Serial Number85414847
Word MarkNOVOPROTEIN
Filing DateSaturday, September 3, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 7, 2019
Registration Number4236251
Registration DateTuesday, November 6, 2012
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 21, 2012

Trademark Statements


Indication of Colors claimedThe color(s) orange is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the wording "novoprotein" in soft orange stylized lower case letters.
Goods and ServicesProtein and biochemical compounds in the nature of peptides for industrial, laboratory and research use; chemical analysis kits containing protein and peptides for industrial, laboratory, and research use; protein and biochemical compounds in the nature of peptides in raw material form for scientific research; cytokines and recombinant proteins for laboratory and research use; bio-chemicals, namely, antibodies for laboratory and research use; enzymes for laboratory and research use; enzymes derived from biotechnological processes for use in industry; enzymes for scientific and research purposes; biochemical reagents used for non-medical purposes; molecular biology reagents for laboratory or research use; protein detection and analysis reagents for laboratory or research use; diagnostic enzymes and reagents for laboratory or research use; and enzyme substrates for laboratory or research use
Goods and ServicesResearch and development in the biotechnology fields, namely, conducting protein expression and purification, using mammalian, Baculovirus insect cell, E. coli, and yeast cell expression systems for protein expression and purification, large scale protein production in a gram scale, antibody production, custom rabbit polyclonal antibody production, hybridoma and in vitro monoclonal antibody production, antibody fragmentation, antibody labeling, protein modification, PEGylation, metabolic labeling with stable isotopes, protein crystallization, crystal screen and optimization, co-crystallization with compounds or ligands, molecular cloning, gene synthesis, site-directed mutagenesis, subcloning, and large scale plasmid production

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 7, 2019
Primary Code001
First Use Anywhere DateSunday, November 1, 2009
First Use In Commerce DateFriday, April 1, 2011

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 7, 2019
Primary Code042
First Use Anywhere DateSunday, November 1, 2009
First Use In Commerce DateFriday, April 1, 2011

Trademark Owner History


Party NameNovoprotein Scientific Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN

Party NameNovoprotein Scientific Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN

Party NameNovoprotein Scientific Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN

Trademark Events


Event DateEvent Description
Friday, June 7, 2019CANCELLED SEC. 8 (6-YR)
Monday, November 6, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 6, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, August 21, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 16, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 12, 2012ASSIGNED TO LIE
Friday, June 22, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 22, 2012EXAMINER'S AMENDMENT ENTERED
Friday, June 22, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 22, 2012EXAMINERS AMENDMENT E-MAILED
Friday, June 22, 2012EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 20, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 20, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 20, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 20, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 22, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 22, 2011NON-FINAL ACTION E-MAILED
Thursday, December 22, 2011NON-FINAL ACTION WRITTEN
Wednesday, December 21, 2011ASSIGNED TO EXAMINER
Thursday, September 8, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, September 7, 2011NEW APPLICATION ENTERED IN TRAM